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Abstract
Parkinson’s disease (PD) is a multifactorial disease known to result from a variety of factors. Although age is the principal risk
factor, other etiological mechanisms have been identified, including gene mutations and exposure to toxins. Deregulation
of energy metabolism, mostly through the loss of complex I efficiency, is involved in disease progression in both the genetic
and sporadic forms of the disease. In this study, we investigated energy deregulation in the cerebral tissue of animal models
(genetic and toxin induced) of PD using an approach that combines metabolomics and mathematical modelling. In a first
step, quantitative measurements of energy-related metabolites in mouse brain slices revealed most affected pathways. A
genetic model of PD, the Park2 knockout, was compared to the effect of CCCP, a complex I blocker. Model simulated and
experimental results revealed a significant and sustained decrease in ATP after CCCP exposure, but not in the genetic mice
model. In support to data analysis, a mathematical model of the relevant metabolic pathways was developed and calibrated
onto experimental data. In this work, we show that a short-term stress response in nucleotide scavenging is most probably
induced by the toxin exposure. In turn, the robustness of energy-related pathways in the model explains how genetic
perturbations, at least in young animals, are not sufficient to induce significant changes at the metabolite level.
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Introduction
Parkinson’s disease (PD) is a pernicious neurodegenerative
disease for which no cure exists. Two important cellular hallmarks
of this disease are the formation of cellular inclusions named Lewy
Bodies, and the degeneration of dopamine-containing neurons of
the ventral midbrain, mainly within the substantia nigra pars compacta
[1,2]. Lewy bodies appear to be the result of a degenerative
metabolic process implicating the aggregation of alpha-synuclein
protein, and the failure of energy-intensive biochemical mecha-
nisms such as disposal of damaged proteins [3]. Since the disease
arises from different causes: environmental toxicity, genetic
mutations and brain aging, general disease prevalence can hardly
be defined [4]. However, fundamentally to all biological systems,
metabolic energy homeostasis is critical, especially in cells that
consume energy at high rates, such as brain neurons.
Toxins used in farming, such as paraquat (herbicide), rotenone
(pesticide) and maneb (fungicide) are known to induce specific PD-
related symptoms in animal models [5]. These toxins inhibit
mitochondrial complexes 1 (paraquat and rotenone) and 3
(maneb) involved in cellular respiration. Also, solvents such as
toluene and n-hexane, and carbon disulfide used in solvents and
pesticides, have been shown to cause neuronal death by
mitochondrial damage [6]. MPTP (1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine), inadvertently obtained in the incomplete
synthesis of the recreational drug MPPP (49-methyl-a-pyrrolidi-
nopropiophenone), leads to rapid appearance of PD symptoms
within few days [7–9]. Similarly to other ionophores, MPTP
uncouples cellular respiration and leads to a complete shutdown of
mitochondrial function and of other cellular processes. Genetic
mutations related to PD have been found in seven different genes:
PARK1, 3, 5, 8 (dominant) and PARK2, 6, 7 (recessive). These
genes encode proteins involved in neurotransmission (PARK1),
protein quality control and cellular stress responses (PARK2,
PARK5, and PARK7), regulation of mitochondrial function
(PARK6) and in the regulation of the cyclosqueleton and
protein-protein interactions (PARK8) [10]. Even though familial
forms of PD are not frequent (at most 20% of all PD cases),
elucidation of their molecular mechanisms could help to identify
causes of more common idiopathic forms of the disease [11–13].
Interestingly, a final common pathway of many PD gene defects
appears to be mitochondrial dysfunction with perturbations of
cellular energy production. In addition to the above-mentioned
factors, cellular dysfunctions linking PD to aging are not
completely identified, however it is known that the latter involves
reduced availability of metabolic energy and impaired clearance of
damaged proteins and cellular by-products. Therefore, it is likely
that this third factor is also linked to impaired regulation of cellular
energy [14].
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In this work, we have studied the effect of PD-related
perturbations on brain cells metabolism. Metabolites were
measured in brain tissue from Parkin KO (knockout) mice, as
well as in brain tissue exposed to the complex I antagonist CCCP
(carbonyl cyanide m-chloro phenyl hydrazone). The genetic model of
Parkinson’s disease selected for the present study was Parkin KO
mice that present mitochondrial efficiency reduction. This gene is
situated on locus 6q25.2–q27 [15] and codes for a E3-ubiquitin
protein ligase [16] involved in the degradation of damaged
proteins through the Ubiquitin Proteasome System (UPS) [17].
Parkin is also involved with Pink1 in mitophagy, a quality control
mechanism removing damaged mitochondria [18]. Impaired
mitochondrial and protein degradation may lead to protein
aggregation and perturbed cellular energetics. In the present
study, animals were produced by mating heterozygote mice to
obtain KO and wild-type (WT) littermates. Because a number of
toxins such as MPTP, and PD gene mutations including those in
the Parkin gene, perturb mitochondrial function and in particular
the complex I, we compared tissues obtained from Parkin KO
mice to WT tissues treated with CCCP. This ionophore is known
to dissipate the pH gradient across the mitochondrial membrane,
leading to the loss of ATP production, an energetic shuttle critical
for cellular metabolism [19].
As expected, energy production pathways are extremely robust
because of multiple feedback interactions, which in turn, induce
emergent properties such as homeostasis [20]. These regulatory
properties are likely to be extremely important in how the brain
reacts to the energetic perturbations/stresses occurring in PD.
However, it is extremely tedious to investigate this issue with
experimental data alone [21]. In that context, a dynamic
modelling platform can efficiently complement experimental
studies [22,23]. To evaluate the relative implications of measured
ex-vivo data, an in-silico platform was developed and model
simulations were used to rationally integrate the experimental
dataset and then allow studying mice brain cells metabolomic state
behaviour. From model simulations, we attempted to model the
impact of parkin gene KO and complex I blockade on energetic
cell metabolism. Therefore, in order to assess the dynamics of
metabolic events involved in this phenomenon, we developed a
kinetic-metabolic model describing concentrations in nutrients and
cell metabolites, as well as metabolic fluxes with time, in brain
tissue. The current study thus presents a kinetic-metabolic model
of central metabolism and energy metabolic pathways describing
the dynamics of energy related metabolites after PD inducing
perturbations.
Materials and Methods
The protocols that require evaluation have been approved by
the ‘‘Ethics committee of animal experimentation’’ of the
Universite´ de Montre´al.
Slice Preparation
Mouse brain slices were prepared and rapidly transferred in
Petri dishes. Two slices were evaluated each 10 min (for a total of
eight time points) and homogenised in an alcohol extractor to
arrest cellular metabolism. In two experiments, a control group
(wild type mouse) was compared to either the genetic model or the
toxin-induced model. Mice were anaesthetized with halothane and
immediately killed by decapitation. The brain was rapidly
removed and placed in ice-cold carboxygenated (95% O2 and
5% CO2) cutting-solution (glycerol-containing artificial cerebro-
spinal fluid (G-ACSF)) containing (in mM): NaCl, 125 mM; KCl,
2.5 mM; KH2PO4, 0.3 mM; NaHCO3, 26 mM; CaCl2, 2.4;
GLC, 10 mM; MgSO4, 1.3 mM; at 300 mOSM. The olfactory
bulbs and cerebellum were removed and the rest of the brain sliced
using a vibrating microtome (Leica VT1000SH) in order to make
300- mm thick coronal slices. During slice preparation, the tissue
was always maintained immersed in 4uC ACSF. Each slice was
delicately transferred to a Petri dish continuously perfused with
oxygenated ACSF. After preparation, brain slices from both mice
were allowed to recover for about 30 min.
Stress and Control Groups
Two brains (a control and a test sample) were sectioned and
processed in parallel for each experiment. Individual slices were
processed at a rate of one per 10 min for a total of about 75 min.
Parkin KO mice on a C57bl/6 background were used as a genetic
model of PD, and their oxidative phosphorylation capacity was
taken to be 90% of that of the wild-type (WT) [17]. Wild-type
littermates were used a control. A subset of slices from WT mice
were exposed to 10 mM CCCP to inhibit complex I function. The
inhibitor was added in the experimental group after the second
sampling, 15 min following the first extraction. After the collection
of two samples exposed to CCCP, remaining experimental slices
were transferred to a Petri dish containing normal ACSF, as for
the control group.
Preparation of Intracellular Extracts
The understanding of cells metabolic activity in response to
perturbations requires the simultaneous evaluation of many
compounds involved in the cellular metabolic network. Several
extraction methods for metabolite analysis have been reported,
and based on previously reported results [24–26] and our own
studies, a modified procedure using cold methanol was found to be
the most appropriate since it combines mild extraction strength
conditions and high enzymatic inactivation.
The two slices selected for each extract were transferred using a
brush from a Petri dish to a centrifuge tube, which was then
centrifuged at 21 000 g at 4uC for one min; the ACSF supernatant
was then removed using a flame-pulled Pasteur pipette. The pre-
weighted centrifuge vial was then reweighted to deduct the
collected fresh brain mass and 200 mL of an 80% v/v mixture of
methanol and water, cooled on dry ice, was added. The tissue was
then homogenized using a motorised pillar, vortexed and
sonicated to disrupt cell membranes, precipitate proteins and
arrest metabolic reactions. An additional 200 mL of methanol/
water was next added and the homogenization, vortexing and
sonication steps were repeated. The samples were maintained at
280uC for further analyses.
The sample was resuspended and vortexed after addition of
0.2 g of sand to improve homogenisation, and micro-centrifuged
at 21 000 g for 7 min at 4uC. The resulting supernatant was
collected and considered as the first extract. After the addition of
0.2 mL of ice-cold 50% v/v methanol/water to the pellet, the
sample was again vortexed, cooled in an ice-water bath and
sonicated for three rounds. The sample was then micro-
centrifuged at 21 000 g and 4uC for 5 min to produce the second
extract; the latter was added to the first. Next, 0.2 mL of ice-cold
water was added to the pellet and the vial was vortexed and micro-
centrifuged at 21 000 g and 4uC for 3 min to give the third extract.
Finally, the vial contained the pooled extracts was micro-
centrifuged at 21 000 g and 4uC for 5 min. The supernatant was
then filtered in a syringe with a 0.2 mm filter (Millipore) and stored
at 280uC until LCMS analysis.
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Sample Analysis
The samples were thawed and vortex mixed before analysis.
Samples were kept at 4uC during LCMS autosampling. Minimal
LCMS autosampling loading was performed since it has been
reported that metabolites degrade faster at higher temperatures,
compared to 280uC.
Nucleotide and organic acids together with sugar phosphates
quantification was performed as described in Hammami et al.
[27]. Quantification of metabolites (nucleotides and organic acids)
was performed by integrating peak areas and using standard linear
calibration curves. Extraction specific concentrations of metabo-
lites were calculated by normalizing the quantity of metabolites in
the slice extracts to the fresh weight of the slices. When the peak
area integration led to extrapolation from the linear standard
calibration curve, proper dilution was performed using 50% (v/v)
methanol in water and the sample reanalysed. The concentration
quantification methods used in the present study refer to whole
biological sample homogenisation; the various cellular compart-
ments components and volumes are summed in global concen-
trations values. Based on this extraction method’s limits, the model
considers an average brain slice cells composition.
Nucleotides Quantification
Nucleotides in extracts were analyzed using a 1290 UPLC
system coupled to a 6460 triple quadrupole mass spectrometer
(Agilent TechnologiesH). Nucleotides were separated by a Sym-
metry C18 column (WatersH) equipped with a Security C18
guard-column (WatersH) using ion-pair method. DMHA (N,N-
dimethylhexylanine, SigmaH) was used as an ion-pair reagent to
improve the signal-to-noise ratio with positive ionization mode.
Figure 1. Energy metabolism model for the cerebral tissue. The states of the model (in capital letters) are defined as follows: GLC, glucose;
G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; FBP, fructose-biphosphate; G3P, glyceraldehyde-3-phosphate; PEP, phosphoenolpyruvate;
PYR, pyruvate; GLY, glycogen; R5P, ribose-5-phosphate; Cr (PCr), creatine (phosphocreatine); LAC, lactate; ACA, acetyl-coenzyme-A; CIT, citrate; AKG,
a-ketoglutarate; SUC, succinate; FUM, fumarate; MAL, malate; OAA, oxaloacetate; GLT, glutamate; GLN, glutamine; NAD (NADH), nicotniamide
adenine dinucleotide (reduced); NADP (NADPH), phosphorylated nicotinamide adenine dinucleotide (reduced); ATP, adenosine-triphosphate; ADP,
adenosine-diphosphate; AMP, adenosine-monophosphate; O2, oxygen; ANPs, non-free adenosine-‘‘n’’phosphate nucleotides; Ve, extracellular volume;
subscript ‘‘e’’ refers to extracellular. Reactions (in italic) are defined in Supplementary Materials. The intracellular volume delimited by the dotted line
refers to the mitochondrial volume.
doi:10.1371/journal.pone.0069146.g001
Metabolomics and In-Silico Analysis of PD Models
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e69146
Sugar Phosphates and Organic Acids Quantification
Organic acids and phosphate sugars concentrations were
assessed using the aforementioned UPLC-MS/MS system using
a HypercarbH column and a Hypercarb pre-column (Thermo
FisherH).
Extracellular Components
ACSF cellular environment samples were taken directly from
the Petri dish. The four major extracellular components such as
glucose, lactate, glutamine and glutamate were measured with a
blood analyser (YSI 2700 Select Biochemistry AnalyzerH). Two
modules were used in parallel; glucose and lactate were measured
simultaneously on an analyser, while another measured glutamine
and glutamate simultaneously.
Statistical Analysis
Data are shown as mean 6 SEM (standard error of mean) of
n=3 independent experiments from brain slices prepared from
three mice. Outliers were removed using box-plot analysis.
Cell Populations
In the present study, complete brain slices were homogenized. It
was therefore not possible to distinguish between metabolites
originating from the different cell types (neurons, astrocytes,
oligodendrocytes, microglia, etc.). Considering that cell popula-
tions are not homogeneous throughout the rostro-caudal extent of
the brain, we were careful to select comparable sets of slices from
control and test samples. In addition, although PD is associated
with the degeneration of a limited number of brain regions
including the locus ceruleus and the substantia nigra pars
Figure 2. Effect of toxin exposure on energy dynamics. Experimental data of WT control (¤) and CCCP stressed (&) brain cells, and model
simulations of control (black line) and CCCP stressed (red line) cells. LACe (A), GLCe (B), LACe to LAC transport (C), GLCe to GLC transport (D), LAC
production (V_ldh) (E), GLC consumption (V_hk) (F), ATP (G), ATP-to-(ATP+ADP+AMP) (¤,&, black line, dotted red line) and ATP-to-
(ATP+ADP+AMP+ANPs) (thick red line) ratios (H).
doi:10.1371/journal.pone.0069146.g002
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compacta, in the present study, brain tissue was collected from the
whole brain. We did not attempt to collect only the ventral
mesencephalon, where the substantia nigra is localized, as this
would have lead to insufficient quantities of cells and thus of
metabolites; an experimental limitation determined from the
detection limit of the LCMS and UPLCMSMS equipments used.
Although in these mice the Parkin gene was knocked out from all
cells, it is possible that by analysing whole brains, we missed
perturbations in cell metabolism that were more specific to the
affected nuclei.
The Model
The metabolic pathways investigated in this study are presented
in Figure 1. Details concerning the model (transient mass balances,
parameters etc.) are provided in the Supplementary Material (SM);
with the description of the kinetic-metabolic model (Table S1),
fluxes’ kinetic formulation (Table S2), fluxes’ functions (Table S3),
state variables and initial conditions (Table S4), maximal fluxes’
rates, affinity, inhibition, threshold, stoichiometric ratios and other
constants (Table S5). All functions in Table S5 are widely used in
control engineering, and a description of secondary parameters
can be found in major textbooks in systems’ dynamics and control
engineering. The model structure and kinetics were taken or
adapted from literature [28–29; and references therein], and it was
implemented in MatlabH (The Mathworks, Inc.H) using the
Systems Biology ToolboxH (SBT) [30]. The model MatlabH code
is provided as supplementary material. The model accounts for
biochemical reactions occurring in all brain cells, mostly neurons
and astrocytes, and was constructed not to represent a specific
cerebral region nor cell type or function. We thus used
concentrations units (mM) for the metabolites and limited the
modelling to a generic set of reactions that are known to occur in
these cell types. This was to ensure a physiologically realistic model
that could eventually be adapted to other experimental investiga-
tions. Most of the molecules involved in the model are present in
relatively large amounts implying hundreds of thousands (or more)
of each molecule for a typical neuron. From a modelling
perspective, this means that the overall reaction system can be
meaningfully modelled within a deterministic framework to
describe cells’ metabolic network and dynamics. Other PD-related
modeling efforts also successfully used this approach [28;31–33].
Pathways Considered
In this work, we have limited our scope integrating central
carbon metabolism and energetic pathways. Pathways represented
in the model originate from a database of combined information
from literature as well as the web-database BioCyc.org [34]. The
model considers molecular transport across the cellular membrane
(identified with prefix ‘‘T’’, as T_glc for the transport of GLC). As
the main influx, glycolysis is described with a high level of detail.
The modelling is focused on highly controlled enzymatic reactions
(e.g. V_pfk for the flux of phosphofructokinase) and important
branch point. The pentose phosphate pathway (PPP), which is the
major pathway for anti-oxidative action, is represented with its two
glycolytic connecting points. Even if the latter pathway is
extensively simplified to a single state, the by-products stoichiom-
etry (regeneration of 2 NADPH for each GLC cycling through
PPP) is consistent with the full pathway. Pyruvate from the
glycolytic pathway is either converted to lactate through reversible
lactate dehydrogenase, or transferred to the mitochondria and
consumed in the TCA cycle. While some intermediates (such as
AKG) can be used as branch point to amino acids (GLT)
consumption/production, the cycle’s main function is to perform
reduction of NAD shuttles to NADH. This in turn allows ATP
regeneration from ADP by oxidative phosphorylation in the
mitochondria matrix. Although this pathway involves many
enzymatic complexes and sub-compartments, a simple one-step
reaction with parallel proton leakage is considered here.
The two major energetic buffers are considered: phosphocre-
atine and glycogen. Creatine kinase transfers the high energy
phosphate link from ATP to Cr and the resulting molecule PCr
can in turn be used to directly regenerate ATP during periods of
high demand. Glycogen is considered as a single state with a
reversible reaction from G6P. Although energy is used to obtain
G6P, glycogen can in turn be used temporarily if GLC transport
becomes limiting during periods of high-energy demand, thus
creating a buffer effect between low and high energy demand
periods [28].
Consideration on States
Most model states are determined as a distinct mass balance
with a rate of change equal to the difference between production
and consumption fluxes. Alternatively, moiety conservation is used
to reduce the number of differential equations, when possible. For
example, the sum of PCr and Cr is constant and Cr can be
expressed as ‘‘Cr = PCrTOT – PCr’’. In those cases, the unique
assumption is that the total pool of metabolites is constant over the
time frame of the experiment. This approach reduces the number
of differential equations and computing time. In energy metab-
olism, some enzymatic activities reach an extremely rapid
equilibrium and this can also be used to reduce the number of
differential equations, while still describing the associated state
variables with algebraic equations. As an example, even if uridine-
triphosphate (UTP) is necessary for glycogen storage, the enzyme
nucleoside diphosphate kinase covers the use immediately and stabilises
the UTP pool with ATP. In the model, we thus only represent
ATP as the global energy currency and its dynamics will be
representative of the overall energetic state.
Parameters Estimation
Although the model presented here could eventually be used to
estimate confidence intervals on the parameters, this was not the
immediate objective of the present work. Our objective was rather
to develop a kinetic-metabolic model structure that can be
challenged with experimental data. Along with this process of
model calibration, we tested its usefulness to retrieve various
fundamental informations (i.e. fluxes, parameter sensitivity etc.)
that can hardly be obtained experimentally, with regards to
energetic regulation during the early events of PD pathogenesis.
Figure 3. Basal indicator for WT and CCCP stressed models.
Model simulation of control (black line) and CCCP stressed (red line)
brain cells oxygen-to-glucose-consumption ratio.
doi:10.1371/journal.pone.0069146.g003
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The parameters of the model were first estimated from the
available literature, as detailed below, and then calibrated
minimizing the error between simulations and experimental data,
as previously described [29]. The measured rate of GLC intake by
the brain tissue was also used to estimate the reaction rates, when
possible. Most of the enzymatic reactions are described using
simple Michaelis-Menten saturation-type kinetics. Being globally
accepted in the scientific community as a satisfactory mathemat-
ical abstraction for substrate-protein interactions, quantification of
the apparent affinity of proteins to their different substrates is
common, as shown by the large amount of work available in
comprehensive shared web-databases like brenda-enzymes.info [35].
Understanding that a model is a simplified representation of a
phenomenon, or of a network of biochemical reactions in this case,
the kinetic parameters determined in this work have to be seen as
global; they also include what is not described, such as metabolic
regulation as well as other biochemical reactions that are taking
place but that are lumped in this model. The parameter values
determined in this work may thus differ from the strict real value
for a biochemical reaction, but bring a global view on a group of
regulated biochemical reactions occurring around each metabolite
described in the model.
KM apparent Affinity
The affinity of protein-substrate interactions has not been
measured for all organisms or cell types. In this work we thus
gathered the most relevant values from the databases. When
possible, the affinity values were taken for mouse brain proteins
(see Table S5 in Supplemental material). Otherwise, the values
come from mammalian cells or from an average of many different
eukaryotic cells. However, these values were only used as
Figure 4. Effect of parkin gene knockout on brain cells energy dynamics. Experimental data of WT control (¤) and parkin knockout (&)
brain cells, and model simulations of control (black line) and parkin knockout (bleue line) cells. LACe (A), GLCe (B), LACe to LAC transport (C), GLCe to
GLC transport (D), LAC production (V_ldh) (E), GLC consumption (V_hk) (F), ATP (G), ATP-to-(ATP+ADP+AMP) ratio (H).
doi:10.1371/journal.pone.0069146.g004
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reasonable first estimates and were later adjusted during model
calibration process.
Feedback Regulation
In addition to multi-substrate and reversible Michaelis-Menten
flux expression, for specific enzymes or pathways, the mathemat-
ical description requires complementary feedback expressions to
improve its robustness and fidelity with regards to commonly seen
processed such as energy homeostasis. Hill inhibition kinetics on
phosphofructokinase, threshold activation and inhibition of
glycogen on the glycogen buffer pathway, and ADP to ATP
ratio-controlled oxidative phosphorylation are examples of feed-
back regulation mechanisms that were implemented.
VM Maximal Flux Rates
The maximum rate of model fluxes, especially glycolytic fluxes,
can be estimated from the basal (i.e. before perturbation) GLC
uptake rate and LAC excretion rate, as measured from the
extracellular GLC and LAC concentrations. The rate of GLC
intake imposes a global limit on the glycolytic fluxes and also on its
branchpoints; the sum of fluxes at a branchpoint has to balance
when in the ‘baseline’ steady-state. The rate of LAC excretion
indicates, indirectly, the proportion of GLC that underwent
complete oxidation, which in turn is an estimate for the TCA
fluxes. Thus, with known values for the KM and other kinetic
parameters (Table S5), if we have an estimate of the flux and
measurements for all of the concentrations, the kinetic equation
can be solved with VM as the only unknown. This gives a realistic
estimate for these parameters, at least for the ‘baseline’.
Subsequently, model fine-tuning was done both manually and
with computational optimisation routines included in the SBT. As
presented below, the model could benefit from further optimisa-
tion for specific experimental cases. However, within the scope of
this work, we considered sufficient to achieve a satisfactory overall
fit with one set of parameters for all of the experimental
conditions.
Stress Implementation
Another addition was also made to the model to allow a sudden
change linked to the addition of CCCP to the media (or in our
case, the transfer of slices in a CCCP prepared ACSF). Because
this ionophore uncouples the respiration chain as it increases
proton leakage across the membrane barrier, the stress is
represented in the model as an increase of the natural
mitochondrial leakage process. As the proton gradient has a
direct effect on the efficacy of the oxidative phosphorylation
pathway, and considering that pH gradients are not represented in
the model, the leakage is modeled as oxidizing directly NADH to
NAD without ADP phosphorylation to ATP. As the stress was
implemented as a pulse, such mathematical description is added to
the model using a sigmoidal-shape function. Since the toxin
diffuses easily into the brain slice, a fast acting sigmoid is imposed
in the opening pulse function. Finally, since the CCCP was washed
out of the slice relatively slowly, a slow acting sigmoid is added for
the pulse function closing term.
Results and Discussion
The complete model has 41 fluxes, 38 states, 82 literature
constants, 28 simulation related parameters, five in-vitro calculated
values and 46 in-silico defined parameters (Table S5) from model
calibration step to experimental dataset. The model considers two
zones, the cellular compartment with its interior volumes (cytosol
with mitochondria) and the extracellular medium, which includes
the extracellular matrix space. The model structure and param-
eters value calibration was performed using the experimental data
and literature. In addition to simple weight measures, blood
analysers and LCMS methods allowed for the qualification of 17
compounds, such as GLC, LAC, GLN, GLT, ATP, ADP, AMP,
NADPH, PYR, MAL, SUC, FUM, AKG, G6P, R5P, F6P and
PEP. Only the most significant data are presented in the following,
together with in-silico simulations; the remaining material is
provided in the Supplementary Materials.
In the following sub-sections, ex-vivo measured values from wet-
lab experimentations are presented with corresponding in-silico
results from computer simulations. The comparison of controlled
conditions to toxin exposure and parkin KO genetic modification
are presented successively.
Exposure to Toxins Induces Severe Energy Deregulation
In the wild-type tissue case (Figure 2), the model simulation was
in accordance with extracellular measurements. This indicates that
the overall consumption/production rates in the model are in
accordance with the experimental system.
The observed increase in GLC (+3% over 75 min) is not due to
GLC excretion from the slices. The Petri dish being open to
unsaturated air and sparged with dry gases, significant evaporation
is likely to have happened during the experiment. Effective
metabolites flows were then corrected by estimated evaporation
measurements and analysis of simulated fluxes; results showed that
the effect of evaporation was slightly stronger than GLC
consumption by the slices and thus had to be considered.
On the other hand, in the case of LAC, the increase was much
more significant (+50% in 75 min) and most of the increase is
likely to have arisen from LAC excretion from the slices. This
indicates an imbalance between glycolysis and oxidative phos-
phorylation, which is coherent with previous work on brain
physiology. Furthermore, the basal unstressed consumption ratio
of oxygen-to-glucose indicator, as calculated by equation 1 and
presented in Figure 3, is within the 3.5 to 5.5 range observed
physiologically [36]. This shows that the slicing process and
diffusion within the slice did not seem to affect the overall
metabolic rates. A severe diffusional problem would most likely











Results show that ATP profile for the wild-type tissue did not
exhibit any clear trend, and that experimental and measurement
noise may dominates. In the model, a consistent result (i.e. no
trend) is achieved because the negative feedback on various steps
of energy metabolism produces a homeostatic response in terms of
ATP. More specifically, hexokinase, phospho-fructokinase and
pyruvate kinase enzymes are activated when ATP is low, and
oxidative phosphorylation is inhibited when ATP is high (refer to
section 3.2 and reactions 26 (V_hk), 36 (V_pfk), 38 (V_pk) and the
ADP-on-ATP ratio as considered in reaction 32 (V_op) in Table
S2).
The short-term dynamic response during and following
exposure to CCCP reveals a rapid and significant drop of ATP
concentration that remains until the end of the experimental
period. This dynamic response is reproduced in the model by
different means. The uncoupling of oxidative phosphorylation by
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the CCCP causes the initial drop in energy. In this new state of low
energy, the metabolic regulation for nucleotides scavenging is
initiated [36] as described in equations 5 and 41, respectively from
Table S1 and Table S2. As the recovery from this stress
(nucleotide regeneration) is slow (reaction 16 in Table S2), the
system remains in a low energetic state for the duration of the
experiment.
Although experimental observations are on a relatively short
timescale, it is clear that the exposure to environmental toxins such
as CCCP can induce rapid and permanent changes of energy
metabolism. In our experimental system, ATP levels after
exposure to CCCP are reduced to 25% of their initial levels
without causing immediate tissue death. The latter result comes
from visual observation of the slices and also from the measured
changes in GLC and LAC, showing sustained metabolic activity
after exposure. This indicates a clear metabolic robustness even
after strong perturbations. It is possible that exposure to CCCP-
like toxins such as MPTP (as observed in humans) could be as
severe, with a significant drop in ATP, but without causing
immediate cell death. In the longer term (days or weeks), the lack
of complete metabolic recovery would however certainly lead to
necrosis and loss of dopaminergic neurons, which agree with the
literature on MPTP usage [7].
The only discrepancy between the modelling and experimental
data is the slower LAC increase in the simulation with CCCP
(Fig. 2-A). This suggests that the model with decoupled energy
production tends to re-uptake LACe contributing to re-balance
TCA. The principal cause for this TCA unbalancing is that the
model considers the NADH as a simple proton gradient. This
leads to strong reduction of NADH instead of proton leak and
further over availability of NAD. As a consequence, NADH
production by all NAD single co-substrate consuming enzymes
such as PYR dehydrogenase (V_pdh) and CIT dehydrogenase
(V_cdh) from TCA cycle are up-regulated. Hence, the global
unbalancing of the TCA cycle could be described in a more
complete way if all connected pathways were considered.
However, based on the measurements of extracellular lactate, its
rate of production after 60 min is not significant. Thus the model is
in accordance with this observation as shown in Figure 2.E.
Furthermore, the reduction of NADPH allows such a ‘‘turbo’’
mode for the overall metabolism as seen in Figure 3, where the
oxygen-to-glucose consumption ratio indicator increases to a high
value of 6 after a higher (,9) transient response. Although stable
for the considered timescale, such an operating mode would
eventually lead to higher risk of damage by oxidative stress and
loss of extracellular LAC.
Energy Robustness under Parkin KO Genetic Perturbation
Model simulations are in agreement with extracellular mea-
surements of cell energetics markers (Figure 4). In the same way as
for the control WT case, the KO model has overall consumption/
production rates that agree with that of the experimental system.
Although all profiles are generally similar to the genetically
unaltered model, a slight adaptation can be observed. While
lactate production is still positive, as the flux of lactate
dehydrogenase (V_ldh) is negative, the reaction rate is approx-
imately doubled. This result is probably a metabolic adaptation
following genetic modification. In fact, the deletion of the parkin
gene is likely leading to the accumulation of a number of damaged
proteins, such as misfolded alpha-synuclein, which could lead to
increased oxidative stress, as described by Cloutier and Wellstead
[37]. The most affected pathway of the model for this genetically
induced oxidative stress is the pentose phosphate pathway, since its
important cofactor NADPH allows regeneration (reduction) of
GSSH to GSH of the glutathione oxidative stress reducing
pathway (with glutathione reductase) [38]. Although the magni-
tude of the oxidative stress generation is multiplied by ten in this
case, cells’ energetic regulation seems to compensate for such
strong perturbation. The ratio of pentose phosphate over
glycolysis, with time, (Figure 5) reveals a variation of the
genetically stressed mouse model compared to both control and
CCCP stressed mice models, where simple energy regulation leads
to a global system adaptation at another possible operating point.
The use of the model thus allows detailed description of the
fluxes, invisible from an experimental level. In this case, tissue
from the KO mice exhibits identical molecular concentrations, but
increased reaction rates allowing a sustainable metabolism.
Conclusion
A mathematical model for brain energy metabolism in the
context of PD related stresses has been developed and validated
using experimental data. The major observation from this work is
that environmental exposure to a toxin such as the complex I
inhibitor CCCP is a severe stress in terms of deregulation of energy
metabolism and that a response is initiated when ATP levels are
irreversibly reduced. In the case of the genetic defect examined
(parkin gene KO), the modelling, supported by experimental
evidences, suggests that the biochemical regulation of energy
metabolism increases metabolic flows without affecting the
metabolite concentrations in order to allow the system to adapt
to a certain level of stress. Although the experiments and
simulations are on a relatively short timescale, the results suggest
how energy can be rapidly deregulated by strong environmental
stresses relevant to PD. In the long term, a certain level of
adaptation could certainly occur, but over time, some damage (i.e.
protein misfolding or oxidative stress) would accumulate, leading
Figure 5. Comparison of fluxes and metabolic ratios. Model
simulations of WT control (black line), CCCP stressed (red line) and
parkin knockout (bleue line) brain cells. Characteristic pentose
phosphate pathway flux rate (V_ppp) (A), Glucose consumption rate
(V_hk) –to- characteristic pentose phosphate pathway flux rate (V_ppp)
(B).
doi:10.1371/journal.pone.0069146.g005
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to cellular disorganisation and cell death [37]. Other integrative
modelling efforts also show that irreversible effects could be rapidly
induced in PD [39], which is coherent with the rapid onset of
neuronal dysfunction observed in humans exposed to MPTP [40].
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